Home / Contract Awards / Millennium Lands Potential $185M NASA Safety, Mission Assurance Services IDIQ

Millennium Lands Potential $185M NASA Safety, Mission Assurance Services IDIQ

Millennium Engineering and Integration Company has secured a potential five-year, $185 million indefinite-delivery/indefinite-quantity contract from NASA to provide safety and mission assurance services at the agency’s Goddard Space Flight Center in Maryland.

NASA said Saturday the ordering period under the SMAS II small business set-aside contract will begin from Sept. 1 and run through Aug. 31, 2022.

MEI will help implement agency and center policies for Goddard projects that include systems safety, risk assessment, mission software and ground systems assurance, mission assurance, occupational safety and health regulations at on-site and supplier locations.

The company will also support flight projects and collaborative programs such as James Webb Space Telescope, Origins, Spectral Interpretation, Resource Identification, Security-Regolith ExplorerJoint Polar Satellite System-1 and Geostationary Operational Environmental Satellite missions.

Work also covers support for Wide Field Infrared Survey TelescopeRestore-L and Plankton, Aerosol, Cloud, ocean Ecosystem projects.

Arlington, Virginia-based MEI offers aviation and aeronautics, cyber, defense, healthcare, intelligence and space technology, engineering and programming services to federal government and intelligence community clients.

Check Also

F5 to Buy Shape Security for $1B; Francois Locoh-Donou Quoted

F5 Networks (Nasdaq: FFIV) has agreed to acquire Santa Clara, Calif.-based Shape Security for approximately $1B in cash as both companies aim to help government and enterprise customers secure digital experience with integrated offerings.

Paratek Secures $169M Anthrax Antibiotic Development Contract Under HHS Project BioShield

The Department of Health and Human Services has awarded Paratek Pharmaceuticals a potential a five-year, $169M contract to further develop an antibiotic drug as a potential treatment for inhalation anthrax.